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Individuals with anorexia nervosa (AN) typically display anxious traits prior to the onset of
food avoidance and weight loss that characterize the disorder. Meal associated anxiety
is an especially common clinical feature in these patients, and heightened sensitivity to
sympathetically mediated interoceptive sensations has also been observed. However,
it remains unclear how heightened interoceptive sensitivity relates to experiences of
anxiety before and after meals. To investigate this relationship, we experimentally induced
anxiety and panic symptoms with isoproterenol, a peripheral sympathetic agonist similar
to adrenaline, across several different conditions: during panic provocation, during
anticipation of a 1,000 Calorie meal, and after meal consumption. Fifteen AN and 15
age- and sex-matched healthy comparisons received bolus infusions of isoproterenol
and saline in a double-blinded, randomized design. Participants rated anxiety symptoms
after each infusion, completed panic rating scales, and traced the location of perceived
palpitations on a manikin to index interoceptive “body map” representation. The AN
group reported significantly elevated anxiety relative to healthy comparisons during
infusions before and after the meal, but surprisingly, not during panic provocation. These
symptoms were accompanied by geographical differences in patterns of perceived
heartbeat sensations across each condition. In particular, the AN group localized
heartbeat sensations disproportionately to the chest during meal related saline infusions,
when no cardiorespiratory modulation actually occurred. The AN group also showed a
trend toward higher panic attack rates during the meal anticipation period. Correcting
for anxiety levels reported during saline infusions abolished group differences in anxiety
change across all conditions, suggesting a significant contribution of anxious traits in
AN. The observation of meal related “visceral illusions” provides further evidence that AN
is associated with abnormal interoceptive representation of the heartbeat and suggests
that meal consumption, particularly when anticipated, preferentially alters the processing
of interoception related signals in AN.
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INTRODUCTION
Individuals with anorexia nervosa (AN) often exhibit heightened
anxiety well before the onset of food avoidance and weight loss
that characterize the disorder (1), and anxious traits are frequent
precursors to the morbid diagnostic characteristics of AN (2–
4). Anxiety is also over-represented in first-degree relatives of
affected individuals (5, 6), supporting the idea that anxious
processes are intrinsic to the developmental risk architecture
of the illness (7, 8). Despite these and other indications of
links between anxiety and eating disorders (2, 9–14), there
is a paucity of research into the potential pathophysiological
mechanisms of anxiogenesis in AN. For example, it is presently
unclear to what extent subjective experiences of anxiety reported
by individuals with AN are primarily due to anxious traits
(that might generate heightened but nonspecific arousal levels),
or whether they are exaggerated by aversive anticipation,
and if so, whether aversive anticipation is generalized or is
selectively modulated by specific contexts such as hypervigilance
toward food cues (15, 16), intolerance of uncertainty (11),
or discomfort with bodily sensations (17). Furthermore, it is
unknown whether anxiety related to sympathetically mediated
interoceptive sensations is generally heightened in AN, if it is
additionally impacted by anticipatory or after-effects of eating,
or both.
In a previous study we demonstrated that pharmacological
infusions of isoproterenol altered meal related interoceptive
signal processing in AN (18). The general notion was to
systematically perturb the observed body state under different
contexts, either shortly before or after a calorically dense
meal. Isoproterenol evokes transiently increased cardiac and
respiratory sensations by stimulating peripheral beta-adrenergic
receptors in the heart and lungs, in a fashion similar to adrenaline
(19). AN patients reported feeling the isoproterenol induced
sensations (particularly dyspnea) more intensely than healthy
comparison participants when anticipating a meal, suggesting
a heightened sensitivity to interoceptive signals. However,
during the saline infusions the patients also reported feeling
significantly more sensations of palpitations and dyspnea during
the pre-meal period. The fact that no bodily modulation had
actually occurred suggested that this was evidence of abnormal
interoceptive prediction error signaling (20, 21). According
to this model, psychopathology results from a dysregulated
ability to adequately sense what is happening in the body
resulting a turbulent reference state (i.e., a “noisy baseline”) (22),
attentional bias toward threat (23), increased self-related worry,
and dysfunctional learning about bodily states over time (24)
[for an overview of current models of interoception’s role in
psychopathology see (25)]. We did not examine in the previous
study whether these interoceptive prediction errors permeated
other levels of body representation, such as interoceptive
localization, or experiences of anxiety. This is important as higher
doses of isoproterenol can elicit panic anxiety (26–28), making it
difficult to discern whether the physiologically induced arousal
leading to subjective feelings of interoception and anxiety can
be dissociated from the anxiousness that is part of the AN
phenotype.
In the current study we investigated these issues by
assessing the impact of meal anticipation and consumption on
interoceptively induced anxiety in AN. To conduct this analysis,
we examined previously unreported data from our prior study
(18) consisting of panic anxiety and body map ratings. We
considered three questions: (1) Does the peripheral modulation
of interoceptive sensation with isoproterenol disproportionately
increase subjective anxiety associated with meal presentation
in AN? (2) Is there a greater panic inducing effect of
isoproterenol infusions in AN, irrespective of meal proximity?
(3) Is there accompanying evidence of abnormal mapping
of bodily sensation that would indicate a disturbance of
interoceptive representation in AN? In regard to the first
question, we predicted that individuals with AN would display
greater isoproterenol-induced anxiety during a meal challenge.
In regard to the second, we predicted that individuals with AN
would display greater panic anxiety than healthy comparisons
during a panic provocation task. In regard to the third
question, we predicted that there would be group body
map differences, but we did not pre-specify the direction
or location due to a lack of pre-existing literature on this
topic.
MATERIALS AND METHODS
Participants
Fifteen individuals with current or lifetime DSM-5 criteria for
AN and 15 healthy comparisons (HC) completed the study1
(Table 1). Diagnoses were verified by a clinician using the
Mini International Neuropsychiatric Interview (MINI version
6.0) (29). We adopted DSM-5 criteria for AN, principally
reflecting the removal of the amenorrhea requirement; diagnoses
of comorbid disorders were verified using DSM-IV criteria.
HCs were also screened for current major psychiatric illnesses
with the MINI, and all participants were screened for lifetime
neurological, cardiac and respiratory disease. While AN was
required to be the primary disorder in terms of clinical
severity, we allowed select comorbid diagnoses in order to
obtain a sample representative of patients commonly treated
in community settings (Table 2) (see Supplementary Methods
for further details). To prevent potential interference with
the measurement of panic anxiety, we specifically excluded
patients with comorbid panic disorder. To ensure they were
not in the acute starvation state, participants with AN were
required to have a minimum body mass index (BMI) above
17 on the day of testing. The study was approved by the
Institutional Review Board of the University of California Los
Angeles (UCLA) and the UCLA Clinical and Translational
Research Center Review Committee. All participants provided
written informed consent and received compensation for their
participation.
1Two HC participants were excluded due to incomplete data and two AN
participants were excluded due to abnormal electrocardiogram changes during the
study. This study was not registered as a clinical trial as the data were collected
prior to the updated guidelines on categorization of clinical trials. Accordingly, a
CONSORT diagram is unavailable for the study.
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TABLE 1 | Demographics and baseline self-report measures.
Measure Anorexia
nervosa
mean (SD)
unless specified
Healthy
comparison
mean (SD)
unless specified
t-Test
(df = 28)
p
Age (years) 23.0 (3.8) 22.3 (4.5) 0.48 0.63
Sex (%) 15
females
(100%)
15
females
(100%)
– –
Body mass index
(BMI)
19.2 (1.6) 22.7 (3.7) 3.27 0.004
Ethnicity (%
Caucasian)
60 40 – –
Education (years) 14.7 (2.5) 14 (2.2) 0.87 0.39
BDI 12.1 (6.9) 2.1 (2.1) 5.42 <0.001
BAI 13.8 (8.3) 3.1 (3.2) 4.63 <0.001
EDE–global score 2.8 (1.4) – – –
Baseline heart rate
(bpm)
70.1
(12.4)
70.5 (9.3) 0.10 0.92
CD25–baseline 5.2 (4.6) 4.0 (1.3) 0.99 0.34
CD25–pre meal 5.30 (2.6) 5.3 (2.6) 0.04 0.97
CD25–post meal 7.1 (4.3) 6.2 (3.1) 0.66 0.52
SD, Standard Deviation; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory;
EDE, Eating Disorder Examination scale; CD25, Chronotropic Dose 25, isoproterenol dose
in micrograms (mcg) required to increase the heart rate by 25 beats per minute (bpm).
TABLE 2 | Clinical characteristics of participants.
Anorexia nervosa
mean (SD)
unless specified
Healthy comparison
mean (SD)
unless specified
AN restricting subtype (%) 73.3 0 (0)
Age of onset (years) 16 (2.4) –
Illness duration (years) 6.8 (4.1) –
Largest weight loss (lbs) 27.9 (10.2) –
Lowest BMI 15.3 (1.7) –
Comorbid secondary
diagnoses [N (%)]
– –
GAD 4 (27) 0 (0)
MDD 2 (13) 0 (0)
OCD 2 (13) 0 (0)
>2 comorbid disorders 2 (13) 0 (0)
Psychotropic medication
N (%)
4 (27) 0 (0)
Diagnoses based on DSM-5. GAD, generalized anxiety disorder; MDD, major depressive
disorder; OCD, obsessive compulsive disorder.
Infusions
Participants received three sets of isoproterenol and saline
infusions on the same day.
Panic Provocation Assessment
All participants received single blinded bolus intravenous
infusions in the same fixed order as: 0.1 micrograms (mcg)→
saline→4.0mcg→saline→1.0mcg→2.0mcg→saline [protocol
identical to (28)]. We chose this order so that the first several
infusions could: (1) rule out the possibility of adverse (i.e.,
allergic) reactions to isoproterenol, and (2) acclimatize
participants to the experimental setup, so that anxiety reported
during isoproterenol infusion was related to the experience
of isoproterenol-induced sensations rather than anticipatory
anxiety induced by infusion administration. We selected the
4.0 mcg bolus dose in order to maximize the likelihood of
inducing panic anxiety on the basis of: (1) safety, (2) tolerability,
and (3) similar heart rate response to studies using continuous
isoproterenol infusions (30). We included lower doses (1.0
and 2.0 mcg) in order to evaluate the degree to which panic
responses were dose-related and to establish whether baseline
sensitivity to isoproterenol (measured via the chronotropic dose
25 or CD25) differed between groups. CD25, the dose necessary
to increase the participant’s heart rate by 25 beats per minute
above baseline, is a commonly reported measure of peripheral
sensitivity to adrenergic sympathetic stimulation (31, 32), and
it is known to vary in underweight AN (33). Immediately
after each infusion, participants rated the maximum intensity
of how “anxious, tense, or nervous” they had felt during the
infusion on a visual analog scale. Anxiety ratings could range
from 0 (“not at all” or “none”) to 10 (“extremely” or “most
intense ever”). They also completed a panic symptom rating
scale containing all 13 DSM-5 symptoms of a panic attack (34).
To operationalize the experience of panic anxiety we included
several variants in terminology (35, 36). Thus, in addition to
measuring levels of self-reported anxiety, we indexed fear and
panic by having participants rate the terms “scared, fearful or
afraid” and “panicked” [criteria were identical to (28)]. Each
emotion and panic symptom rating could range from 0 (“not
at all” or “none”) to 10 (“extremely” or “most intense ever”),
respectively. To define whether panic anxiety had occurred
during each infusion, intensity rating increases of 50% or more
(i.e.,≥ 5 point increase on the 0−10 scale) in four or more panic
symptoms were required compared with pre-infusion ratings
[similar to (26, 27)] (see Supplemental Methods for further
information).
Meal Assessment
The second and third infusion sets were linked to an assessment
of pre and post meal states. The second infusion set occurred
immediately prior to a 1,000 Calorie meal, while the third
infusion set occurred immediately upon meal completion.
During each pre and post meal infusion set participants
received 14 bolus infusions: 7 isoproterenol (0.1, 0.25, 0.5,
0.75, 1.0, 2.0, 4.0 mcg), and 7 saline. Infusion administration
was randomized and double blinded per previous protocols
from our group (18, 19, 37). Participants rated their experience
of internal body sensations during and immediately following
bolus infusions. The lowest doses included in these sets
(0.1, 0.25, 0.5, 0.75 mcg) were intended to improve the
detection of deviations in interoceptive awareness from baseline
[as reported in (18)]. They were not expected to induce
panic anxiety, and so we do not report on that aspect
here.
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FIGURE 1 | Experimental timeline. Participants arrived at 7:30 a.m. in the fasting state, at which point their body mass index (BMI) was assessed, and a urine sample
collected to assess pregnancy and substance use status. After eating breakfast (Meal 1) and filling out several questionnaires, baseline heart rate (HR) was measured.
Each infusion set proceeded in order. Participants were reminded about the caloric content and menu for the lunch meal (Meal 2) immediately prior to the second
infusion set.
Meal Protocol
Participants selected two meals (breakfast and lunch) from a
menu that provided three different isocaloric meal options.
Breakfast was provided in order to standardize the timing
between meals. The breakfast calorie content (300 Calories)
reflected a standard meal likely to be recommended during
regular daily intake, and one that prior research has shown is
consumable and less likely to induce severe anxiety in eating
disorder participants in a research setting (38, 39). The lunch
calorie content (1,000 Calories) reflected an amount expected to
be associated with aversive anticipation in individuals with AN,
but not so high that it would be unreflective of a typical lunch
meal consumed by an unaffected individual. For example, from
the lunch menu participants were required to select a dessert
option (cheesecake, chocolate covered ice cream bar, or cookie).2
Calorie content and calorie consumption for each meal was
measured by a registered dietician.
Participants fasted overnight, and ate breakfast upon arrival.
Infusions began 90min afterwards (Figure 1). To maximize
food-related emotional arousal, participants were reminded they
would break for the 1,000 Calorie lunch immediately prior to
the second infusion set, and that they were required to consume
the entire meal. The third infusion set started immediately after
lunch completion.
Apparatus
We recorded heart rate continuously during all infusions with an
MP150 acquisition unit (Biopac Systems, Inc.).
Body Map Assessment
Immediately after each infusion participants were instructed
to “draw the areas where you felt your heartbeat (be as
accurate as possible)” on a paper manikin (identical to (19, 37)).
These outlines were traced manually onto a digital manikin
by an expert tracer blinded to the diagnostic grouping [as in
(40)]. The digital manikin mobile application was developed
and hosted on the Chorus platform (41, 42). Before moving
2Participants were informed that regardless of the meal option selected, breakfast
contained 300 Calories and lunch contained 1000 Calories.
further a reliability check across 90 randomly selected maps,
traced onto the digital manikin by a second tracer, yielded an
inter-tracer Dice (43) similarity coefficient ≥ 0.77, suggesting
quantitatively reliable agreement comparable to other published
manual tracing approaches (44).We then calculated proportional
bodymaps from the binary tracings for each group and condition
(Supplementary Figure 1), selecting only doses for which all
15 participants generated tracings (saline, 2.0, and 4.0 mcg).
Thus, each pixel value in the proportional map was equal to
the total number of participants reporting sensation in that
pixel (maximum of 15) divided by total number of participants
(maximum of 15). We then applied spatial smoothing using a
Gaussian kernel with full width half maximum of 6 pixels. This
smoothing size was determined from the inter-tracer reliability
analysis, representing half of the average non-overlapping areas
observed between the two tracers.
Statistical Analysis
Demographic data were analyzed via independent samples
t-tests. Continuous data were analyzed using general linear
models with repeated measures, with group, condition (panic
provocation, pre meal, post meal) and dose as fixed effects and
individual participants as random effects. In order to differentiate
meal related effects, data from the pre meal and post meal
infusions were entered into the same analysis. Dichotomous
variables were analyzed using the Chi square test. All tests were
two tailed, and p-values ≤ 0.05 were considered statistically
significant.
Statistical Analysis of Body Maps
To evaluate between-group differences in the body maps, for
each pixel, we calculated the test statistic using the z-formula for
proportion (45)
z =
pAN − pHC√
pTot(1− pTot)
√
1
NAN
+
1
NHC
where pAN is the proportion of participants in the AN group
who reported having sensation on that pixel and pHC is the
same for the HC group, pTot is the proportion of participants
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having sensation when both groups are combined, and NAN
and NHC are the number of participants in the AN and HC
groups. To estimate the p-value for the calculated z-value, we
performed a permutation analysis in Matlab (Mathworks, Inc.).
In this analysis, we assumed that under the null hypothesis, the
group labeling of participants (AN or HC) is arbitrary, and one
can estimate the probability distribution of the test statistic under
the null hypothesis by relabeling participants many times and
computing the test statistic. When participants are independent
from one another, the total number of possible relabelings
would be (NAN+NHC)!/(NAN! NHC!). We used 5,000 relabelings
(Nres, randomly selected from all the possible relabelings)
which resulted in an acceptable precision error for the p-value
estimation (<0.0001) via a random permutation or Monte-Carlo
permutation test procedure [modeled after (46)]. The p-value
for each pixel was subsequently calculated by computing the
number of occurrences of z-value in the resampled conditions
equal or larger than the z-value of the actual sample. Pixels with
p-values ≤ 0.05 were considered to have significantly more hits
(i.e., reported to have sensation) by group AN compared to group
HC (47) (see Supplementary Methods for further details).
RESULTS
Heart Rate Response
Both groups exhibited similar resting heart rates at baseline
[t(28) = 0.10, p = 0.92] (Table 1). While the bolus isoproterenol
infusions elicited significant dose-dependent responses across
each condition, there were no significant group differences
across any of the conditions (Supplementary Figure 2, see
Supplementary Results).
Meal Consumption
During screening and eligibility assessment, several potential
participants refused to enroll in the study since they were
uncomfortable with the amount of calories in the lunch meal. Of
the individuals who consented to participate in the study, they
all consumed the breakfast meal in entirety, and there were no
significant group differences in lunch calories consumed between
groups [F(1, 28) = 1.48, p= 0.24](see Supplementary Results for
further details).
Anxiety Ratings
The AN group reported greater levels of anxiety at baseline,
prior to starting the panic and meal infusion conditions
[F(1, 28) = 6.4, p = 0.018]. They also reported a trend
toward higher levels of isoproterenol-induced anxiety during
the panic condition [F(1, 28) = 3.3, p = 0.08) (Figure 2A), and
significantly higher anxiety across meal conditions [F(1, 28) = 7.8,
p= 0.009] (Figures 2B,C). However, after controlling for anxiety
experienced during saline infusions, there were no longer any
group differences observed in the magnitude of anxiety increase
from low to high doses. This was true for the panic condition
[F(1, 28) = 0.02, p= 0.89] (Figure 2D) and across meal conditions
FIGURE 2 | Retrospective anxiety ratings during isoproterenol infusion. (A) Anxiety during panic provocation condition. The group effect showed a trend toward
significance (#p = 0.08). (B) Anxiety during pre meal infusion, prior to consuming a 1000 Calorie meal. There was a significant group effect (*p = 0.009). (C) Anxiety
during post meal infusion, after consuming a 1,000 Calorie meal. There was a significant group effect (*p = 0.009). (D) Corrected anxiety during panic provocation.
Anxiety was baseline corrected by subtracting the average anxiety reported during saline infusions from the anxiety reported at each dose. There were no group
differences in anxiety during the panic provocation (D), pre meal (E), or post meal (F) conditions. Axis markers for the 0.25 and 0.75 mcg doses are omitted to
improve figure clarity. AN, anorexia nervosa; HC, healthy comparison; NS, non-significant.
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[F(1, 28) = 0.75, p = 0.39] (Figures 2E,F). There were also no
significant group by dose interactions for anxiety in the panic
provocation condition, under either uncorrected [F(1, 3) = 1.99,
p = 0.12] or corrected [F(1, 3) = 1.73, p = 0.17] conditions.
Similarly, for the meal condition there were no significant
group by meal interactions for anxiety under either uncorrected
[F(1, 1) = 1.3, p = 0.26] or corrected [F(1, 1) = 0.76, p = 0.39]
conditions. There were no significant three-way interactions
(group × meal × dose) for isoproterenol induced anxiety under
either uncorrected [F(1, 6) = 1.64, p = 0.18] or corrected
[F(1, 6) = 1.21, p = 0.30] conditions. These results indicate that
while anxiety levels were higher in the AN group overall during
the meal related conditions, the amount of change in subjectively
experienced anxiety from low to high doses was similar for both
groups.
Panic Rates
There were no significant group differences in the overall rate of
panic anxiety for panic provocation [(χ2(1) = 1.79, p = 0.18],
the pre meal [(χ2(1) = 3.07, p = 0.08], or post meal condition
[χ2(1) = 1.37, p = 0.24]. Given the trend toward significance
in the pre meal condition, and our intention to evaluate for
meal related effects, we examined whether there was evidence
of a differential panic rate at individual doses. We found that a
significantly greater proportion of the AN group panicked during
the premeal condition at the 2mcg dose [χ2(1) = 3.96, p= 0.046]
(Figure 3).
Interoceptive Representation
We observed qualitative group differences in the topographies of
heartbeat sensation localization, as reflected by the proportional
body map distributions (Figure 4A shows an example for the
pre meal saline condition). These differences were confirmed by
quantitative differences in the statistical body maps (Figure 4B).
Inspection of all statistical body maps revealed different patterns
in the geographical localization of heartbeat sensation body maps
across each condition (Figure 5). During the saline infusions,
when no exogenous cardiorespiratory perturbation occurred, the
HC group reported more sensation in the inferolateral chest and
neck in the panic provocation condition, whereas during themeal
conditions the AN group reported disproportionately greater
sensations in the superolateral chest, upper abdomen, upper
back, and vertex of the head. During the 4 mcg infusions, when
similar physiological responses were observed in both groups,
the HC group preferentially reported heartbeat sensations in the
neck, face and left lateral chest across conditions, whereas the AN
group preferentially reported heartbeat sensations in the right
lateral chest, posterior neck, and upper back predominantly in
the meal conditions (especially pre meal).
Exploratory Analysis: Pre vs. Post Meal
Anxiety
Since the AN group showed evidence of heightened meal
associated anxiety consistent with our a priori hypothesis, we
conducted an exploratory analysis to examine whether there were
differences in pre and post meal anxiety at the level of individual
doses. We observed a general pattern of decreased post meal
anxiety only in the AN group (Figures 6A,B). At the individual
dose level the AN group showed a statistically significant
reduction in post meal anxiety at 0.5 mcg [t(28) = 2.44, p= 0.026,
two tailed, uncorrected]. Plotting individual anxiety reductions
at this dose revealed that the majority of AN participants (10
out of 15) reported lower post meal anxiety, with a minority
showing no change (3 out of 15) or an increase in anxiety (2
out of 15) (Figure 6C). Only a minority of HCs reported lower
post meal anxiety (3 out of 15) whereas the majority showed
no anxiety change (9 out of 15), or an increase (3 out of 15)
(Figure 6D).
DISCUSSION
In the current study of AN we experimentally manipulated
interoception related anxiety and panic symptoms in the same
context as meal consumption. There were several important
findings related to our hypotheses: (1) Contrary to our
hypothesis the relative change in anxiety from low to high
FIGURE 3 | Panic attack rates during bolus isoproterenol infusions. (A) For the panic provocation condition, there was no significant difference in the panic rate
across all doses (p = 0.18) or at the individual dose level. (B) For the pre meal condition, there was a trend toward a higher panic rate in AN across all doses
(p = 0.08), and there was a significantly higher panic rate at the 2.0 mcg dose (p = 0.013). (C) For the post meal condition, there was no significant difference in panic
rate across all doses (p = 0.24) or at the individual dose level.
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FIGURE 4 | (A) Proportional body map showing group differences in heartbeat sensation topography during the pre meal infusions of saline. The AN group showed a
higher percent overlap in the chest as well as heartbeat sensations in the upper abdomen and extremities. (B) Statistical body map (thresholded at p ≤ 0.05) for the
same condition showing that only a subset of these regions reached statistical significance: the AN group reported feeling heartbeat sensations more frequently in the
upper left chest and upper right back during pre meal infusions of saline.
doses was similar for both groups. The absolute levels of
interoceptively induced anxiety were higher in the AN group
across the meal period, suggesting a backdrop of heightened
meal related anxiety expression in the AN group. (2) Also
contrary to our prediction, the AN group failed to show
a greater panicogenic sensitivity to isoproterenol infusions
during non-meal related panic provocation. Instead, there was
a trend toward greater panicogenic effect of isoproterenol
infusions in AN during meal anticipation (significant at
the 2.0 mcg dose), supporting the possibility that meal
anticipation represents a specific temporal window of heightened
interoception related anxiety susceptibility in AN. (3) Using body
maps to index interoceptive representation, we found that the
AN group showed discrepancies in the geographical localization
of heartbeat sensation, suggesting the presence of abnormal
interoceptive body representation. We consider the implications
of these findings in further detail below.
Consistent with many other studies of AN which have
observed higher trait anxiety levels (2, 9, 10) we found that
the AN group reported heightened anxiety across multiple
contexts: in self report scales at study entry (i.e., Beck Anxiety
Inventory), during baseline visual analog scale ratings prior to
receiving any infusions, and during intravenous infusions in
which no physiological changes were induced (i.e., saline). This
finding was unsurprising. The observation that both groups
reported similar increases in anxiety from low to high doses
after accounting for these baseline differences was surprising,
and went against our predictions. It underscores the degree
to which nonspecific dimensional factors (perhaps such as
anxious temperament, hypervigilance, discomfort with bodily
sensations, and weight gain induced fear) might contribute
to baseline reports of heightened anxiety in clinical settings.
For example, in the current study patients in the AN group
reported on average experiencing anxiety at intensity levels of
approximately 2 out of 10 across all saline infusion conditions,
compared with the HC group’s reported anxiety intensity level
of approximately 0.5 out of 10. Given the similar increases in
interoceptively induced anxiety across both groups, we speculate
that interventions capable of reducing these baseline levels
of heightened anxiety could potentially buffer patients from
experiencing higher situational anxiety (as in the case of meal
onset periods).
In an exploratory analysis we observed some evidence of
attenuated anxiety in the AN group during exposure to low
doses of isoproterenol (particularly 0.5 mcg) from pre to post
meal time periods. Although this exploratory finding needs to be
confirmed in a separate study, we believe that any observation
of a reduction in anxiety across the meal period in AN warrants
attention. For example, the attenuated response could relate
to the development of affective tolerance to the drug due to
a weakened stimulus-response pairing (i.e., habituation), or
alternatively, anxiety relief associated with removal of exposure
to food, an anxiogenic stimulus (i.e., negative reinforcement).
Additional experiments could determine which of these two
possibilities was most likely. This is important because pre
meal anxiety poses a frequent challenge in AN treatment
settings: it is associated with lower caloric intake and has
been proposed as a potentially important therapeutic target
(38). Unfortunately, typically effective anxiolytic medications
such as alprazolam are ineffective in individuals with AN, and
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FIGURE 5 | Statistical body maps (thresholded at p ≤ 0.05) showing quantitative group differences in heartbeat sensation localization during the panic provocation,
pre meal, and post meal conditions. (Top) During the pre and post meal infusions of saline the AN group reported feeling heartbeat sensations more frequently in
different regions of the chest, when no interoceptive perturbations were delivered, whereas during panic provocation saline infusions the HC group reported feeling
heartbeat sensations more frequently in the inferolateral chest and anterior neck. (Bottom) During the 4 mcg perturbations, when similar physiological responses were
observed in both groups, the groups showed opposing patterns: the AN group showed reported feeling heartbeat sensations more frequently in the right side of the
chest during panic and pre meal infusions, whereas the HC group reported feeling heartbeat sensations more frequently in the left chest and upper face during the
post meal infusion. For brevity, only results from the saline and 4 mcg dose are displayed.
they do not increase caloric intake (48). In contrast, cognitive
behavioral therapies for AN utilizing exposure therapy can
promote food intake (49) and increase weight in AN (50),
although the gains are modest and are marked by high dropout
rates. Limited responses to exposure therapy using food may
be related to the fact that this treatment requires AN patients
to voluntarily engage in repeated and sometimes prolonged
confrontation with the primary stimulus that disproportionately
provokes their fear. As a consequence, this type of approach
may be too aversive for many individuals to tolerate, at least
in the early phases of treatment. Recent psychotherapeutic
treatments have instead targeted reinforcing or maintaining
factors in treatment, such as family based interactions around
food (51), anxious temperament (3), reward processing (52,
53), and habit training (54). The current study adds to this
debate by considering whether interoceptive interventions to
attenuate anxiety during meal anticipation might warrant further
investigation.
Our observation that heartbeat sensations were felt to
be localized in discrete body regions in the absence of
cardiorespiratory stimulation suggests the presence of “visceral
illusions” and provides further evidence that AN is associated
with abnormal meal related interoceptive representation of
the heartbeat. Although we have previously characterized the
bodily localization of isoproterenol-induced heartbeat sensation
in healthy and brain lesioned individuals (19, 37, 40), the
current study demonstrates quantitative group differences in
the mapping of these interoceptive representations in a sample
of psychiatric patients. The finding that patients preferentially
localized illusory sensations to the left side of the chest during
meals in the absence of sympathetic stimulation has several
interpretations. It could be caused by source misattribution (i.e.,
a mistaken belief that the heart is predominantly located on the
left), or alternatively, could reflect the presence of interoceptive
prediction errors as we have previously suggested (18). The cause
of the AN group’s tendency to localize sensations to the back
and lateral aspect of the right chest during actual sympathetic
stimulation, irrespective of condition, is also unclear. Since
individuals with lower BMI have been observed to display
greater cardiac interoception under resting conditions (55, 56),
one potential mechanism could be greater reverberation of
myocontractile force throughout the body due to the lower
BMI in the AN group. Another mechanism could be due to
illness characteristics, such as elevated anxiety or eating disorder
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FIGURE 6 | Pre vs. post meal anxiety. (A) Healthy comparisons (HC). (B) Anorexia nervosa (AN). The AN group reported significantly higher pre meal anxiety during
the 0.5 mcg dose (*p = 0.026, uncorrected). These first two data sets are identical to Figures 2B,C, and are shown superimposed here to better illustrate the within
group differences in meal related anxiety exhibited by the AN group. (C) Individual pre vs. post meal anxiety changes at the 0.5 microgram dose for healthy
comparisons and (D) anorexia nervosa. At this dose most HC participants reported no anxiety during both time points, whereas most AN participants reported anxiety.
symptoms, though this is speculative. To evaluate the role of
illness characteristics a more clinically relevant question would
need to be addressed. Namely, does the presence or absence
of reported somatic sensations in specific body regions help
predict if individuals are anxious, exhibit low BMI, or eating
disorder symptoms? Answering this question would require a
different approach and likely a larger sample than was possible
in the present study. Nevertheless, the current results could be
considered as a proof-of-principle demonstrating the feasibility
of interoceptive body map quantification at the group level. It
is worth noting that this quantitative body mapping technique
shares some general similarities with other recent approaches
(46, 57) in the sense that it employed a graphical interface
and a virtual avatar. However, two fundamental differences
relate to our use of a physiological probe to elicit interoceptive
sensation, and a binary mapping procedure to detect the
presence/absence of sensation across the entire body surface
(front and back).
The current study examined the impact of two specific
probes relevant to the experience of anxiety in AN: physiological
perturbation with a sympathetic agonist, and manipulation
of expectations surrounding consumption of a relatively large
meal. By examining the anxiogenic influences of these probes
separately, we identified evidence (preliminary, given that
findings were at trend level and the sample size was small)
of a synergistic influence of pre meal time periods on the
anxious response to an interoceptive perturbation. This is
clinically informative because it suggests that the anticipation
of a meal constitutes a time when AN patients have a
disproportionate vulnerability to the subjective effects of physical
triggers of anxiety and panic symptoms. This subjective
vulnerability could not be caused by different physiological
reactions to the drug, as both groups showed nearly identical
responses.
The current results are relevant to cognitive-behavioral
theories of the etiology of anxiety. For example, the observed
trend for heightened pre meal panic could be driven solely by
increased sensitivity to sympathetically-mediated interoceptive
cues, solely by cognitive cues signaling meal onset, or by a
combination of these two factors. In each case these responses
would be speculated to occur within discrete sectors of the
central nervous system, for example in the insular cortex or
amygdala in the case of heightened interoceptive sensitivity
(28, 40, 58–60), and/or in the prefrontal cortical and striatal
regions in the case of cognitive processing cues (59, 61).
Our prior observation of abnormally intense isoproterenol-
induced sensations of dyspnea in AN during meal anticipation
(18), and recent findings of abnormal insula activation during
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respiratory stimulation in women remitted from AN (62)
suggest that erroneous processing of interoceptive respiratory
cues is a key contributing factor. While we cannot rule
out an additional role for cognitive processing from these
studies, future work incorporating parametric designs (e.g.,
high/low interoceptive/cognitive loading) could help distinguish
individuals with disproportionate sensitivity to each process,
leading eventually to personalized interventions. For example,
knowing whether the source of anxiety in a particular AN
individual comes from sensitivity to interoceptive vs. meal related
(cognitive) cues would help to develop a personalized medicine
approach. In this type of treatment, targeting the mechanisms
underlying an individual’s pathology (e.g., interoceptive vs.
cognitive vs. both) might lead to more specific and effective
improvement in symptoms. From a practical standpoint, if the
process of anticipating a meal induces illusory and aversive
bodily perceptions in AN individuals, then training them to
be aware and non-reactive to such illusory signals might
better allow them to focus on ongoing rather than anticipated
sensory signals. Whether this type of intervention would
concomitantly reduce anxiety awaits further investigation. The
current study helps by laying the groundwork for such future
interventions.
Limitations and Future Considerations
The current study has several limitations. (1) The small sample
size effectively prevented examination of potentially relevant
covariates, such as the effects of medication status and co-
occurring disorders. Replicating this experiment in a larger
sample would help to increase confidence in the observed
findings. However, the approach to separating panic related
effects from meal related effects across multiple features of
interoception can be viewed as a form of deep phenotyping
(63) capable of yielding multiple novel insights. (2) Since we
purposefully excluded patients with comorbid panic disorder in
an effort to avoid introducing a non-specific bias in response
to isoproterenol infusions, we cannot address whether or not
the effects may be greater in this subgroup, or may have been
greater had we not excluded this subgroup. Both outcomes seem
likely as isoproterenol and other pharmacological perturbations
have well described effects on triggering panic anxiety in panic
disorder (64–66). However, had we included such patients we
may have seen group differences in anxiety expression during
the panic provocation condition that were driven by a non-
primary disorder. One way to address the issues of comorbidity
would be to recruit an anxious reference sample (e.g., individuals
with generalized anxiety disorder) and compare their responses
with the AN group. An alternative approach using the RDoC
framework (67) would be to compare responses to isoproterenol
infusions and meal challenges in different sets of groups across
transdiagnostic dimensions of disturbed eating behaviors and
anxiety sensitivity. (3) Panic provocation always occurred pre
meal (rather than in randomized or counterbalanced order), and
thus it could have been potentially confounded by some degree
of meal anticipation. Nevertheless, the fact that panic rates were
not higher in the AN group during panic provocation suggests
that perhaps it was not proximal enough to the meal to have
appreciable effects. (4) The current study did not separately
examine the impact ofmeal related anxiety (i.e., meal anticipation
without infusions), and therefore, was unable to dissociate
anticipatory anxiety linked to meals from the heightened trait
anxiety generally observed in AN individuals. (5) Due to a long
day of data collection interoceptive traits were not measured in
this study, preventing the examination of links between such
traits and the current findings.
CONCLUSION
In summary, the current study provides evidence that meal
related anxiety in AN also encompasses interoceptive processes,
and that AN is marked by meal related differences in the bodily
mapping of interoceptive sensations.
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